DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 1,565 filers reported holding DANAHER CORPORATION in Q2 2020. The put-call ratio across all filers is 1.06 and the average weighting 0.7%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $5,868,061 | +4.4% | 23,652 | +1.0% | 3.15% | +8.9% |
| Q2 2023 | $5,620,800 | -4.7% | 23,420 | +0.0% | 2.89% | -9.1% |
| Q1 2023 | $5,900,508 | -4.3% | 23,411 | +0.8% | 3.18% | -9.4% |
| Q4 2022 | $6,166,237 | +0.6% | 23,232 | -2.1% | 3.51% | -8.2% |
| Q3 2022 | $6,127,000 | +1.4% | 23,722 | -0.4% | 3.82% | +6.1% |
| Q2 2022 | $6,041,000 | -15.2% | 23,827 | -1.9% | 3.60% | +3.4% |
| Q1 2022 | $7,124,000 | -13.3% | 24,287 | -2.7% | 3.48% | -26.5% |
| Q4 2021 | $8,216,000 | +3.3% | 24,972 | -4.4% | 4.74% | -4.8% |
| Q3 2021 | $7,954,000 | +11.6% | 26,127 | -1.7% | 4.98% | +11.0% |
| Q2 2021 | $7,130,000 | +15.3% | 26,569 | -3.3% | 4.48% | +11.0% |
| Q1 2021 | $6,186,000 | -11.8% | 27,482 | -12.9% | 4.04% | -17.7% |
| Q4 2020 | $7,010,000 | -1.8% | 31,556 | -4.8% | 4.91% | -12.1% |
| Q3 2020 | $7,137,000 | +16.1% | 33,146 | -4.7% | 5.58% | +3.2% |
| Q2 2020 | $6,149,000 | +6.9% | 34,771 | -7.2% | 5.41% | +8.8% |
| Q4 2019 | $5,750,000 | +3.3% | 37,466 | -2.8% | 4.98% | -3.3% |
| Q3 2019 | $5,567,000 | -2.2% | 38,544 | -3.3% | 5.15% | -5.6% |
| Q2 2019 | $5,695,000 | +15.3% | 39,849 | -12.4% | 5.45% | +13.7% |
| Q3 2018 | $4,941,000 | +7.0% | 45,476 | -8.6% | 4.79% | +8.1% |
| Q4 2017 | $4,618,000 | -6.2% | 49,757 | -13.5% | 4.43% | -3.3% |
| Q2 2015 | $4,924,000 | +1.4% | 57,530 | +0.6% | 4.58% | +1.6% |
| Q1 2015 | $4,856,000 | -0.2% | 57,190 | +0.8% | 4.51% | -1.3% |
| Q4 2014 | $4,865,000 | +10.7% | 56,760 | -1.9% | 4.57% | +6.4% |
| Q3 2014 | $4,394,000 | – | 57,830 | – | 4.30% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ARTHUR M. COHEN & ASSOCIATES, LLC | 217,436 | $53,823,432 | 13.80% |
| Defender Capital, LLC. | 152,962 | $37,949,802 | 13.74% |
| Bancreek Capital Management, LP | 60,890 | $15,106,809 | 13.58% |
| BOONE CAPITAL MANAGEMENT LLC | 129,163 | $32,045,340 | 10.11% |
| Eagle Health Investments LP | 175,085 | $43,438,589 | 9.57% |
| Third Point | 2,450,000 | $607,845,000 | 9.22% |
| Clio Asset Management LLC | 41,695 | $10,344,530 | 9.04% |
| Consulta Ltd | 500,000 | $124,050,000 | 8.91% |
| Riverstone Advisors, LLC | 47,960 | $11,799,701 | 8.16% |
| CADEN CAPITAL PARTNERS, LP | 123,755 | $27,215,377 | 7.66% |